- BIIB -0.11%
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Yahoo Finance · 11 hours ago
Search results
- 217.81Add to watchlist-0.25 (-0.11%)At close:4:00 PM EDTFri. May 24, 2024218.37 +0.56 (+0.26%)After hrs:6:15 PM EDTFri. May 24, 2024Nasdaq Real Time Price (USD) · Market closed
- Open218.21High219.44Low217.06
- Mkt Cap31.71BP/E (TTM)27.26Div & YieldN/A & N/A
- Prev. Close218.0652 Wk. Low189.4452 Wk. High319.76
What analysts are sayingTop storiesRelated stocks
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
Breaking New Ground With Science. With a strong focus on difficult-to-treat diseases, our pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients and protect public health.
Apr 25, 2023 · The Food and Drug Administration on Tuesday authorized the first drug for a rare genetic form of the neurological disorder A.L.S., despite uncertainty about the treatment’s effectiveness.
As pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to reverse disability, repair damage, and address other remaining unmet needs in MS, with the goal of significantly altering the course of MS and preventing disease development and disability progression.
The potential to transform the lives of patients is what drives us at Biogen. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments.
Everyone at Biogen contributes to our mission to create transformative medicines for people who need them the most. Explore our business areas to discover where you can make an impact on our team.
May 7, 2018 · Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression. January 29, 2023. News Release.
